Hepatic cytoprotection by nitric oxide and the cGMP pathway after ischaemia-reperfusion in the rat

Nitric Oxide - Biology and Chemistry

Volumn 9, Issue 2, 2003, Pages 57-63

  Cottart, Charles Henry ^a   Nivet Antoine, Valérie ^a   Do, Louis ^a   Al Massarani, Ghassan ^a   Descamps, Geneviéve ^a   Xavier Galen, François ^a   Clot, Jean Pierre ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Atrial natriuretic peptide; cGMP; Ischaemia reperfusion; Liver; Nitric oxide; NO donor; SpermineNONOate

Indexed keywords

8 BROMO CYCLIC AMP; ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR ALPHA; CYTOKINE; HYALURONIC ACID; INTERLEUKIN 6; LACTATE DEHYDROGENASE; N(G) NITROARGININE; NITRIC OXIDE DONOR; SPERMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIUM CELL; ENZYME ACTIVITY; LIVER CELL; LIVER CELL DAMAGE; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0242410278     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2003.09.003     Document Type: Article

References (31)

1. Cottart C.H., Do L., Blanc M.C., Vaubourdolle M., Descamps G., Durand D., Galen F.X., Clot J.P. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology. 29:1999;809-813.
2. Kobayashi H., Nonami T., Kurokawa T., Takeuchi Y., Harada A., Nakao A., Takagi H. Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver. J. Surg. Res. 59:1995;772-779.
3. Peralta C., Rull R., Rimola A., Deulofeu R., Rosello-Catafau J., Gelpi E., Rodes J. Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat. Transplantation. 71:2001;529-536.
4. Wang Y., Mathews W.R., Guido D.M., Farhood A., Jaeschke H. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia. Shock. 4:1995;282-288.
5. Pannen B.H., Al Adili F., Bauer M., Clemens M.G., Geiger K.K. Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat. Hepatology. 27:1998;755-764.
6. Denninger J.W., Marletta M.A. Guanylate cyclase and the. NO/cGMP signaling pathway. Biochim. Biophys. Acta. 1411:1999;334-350.
7. Chausse A.A., Nivet-Antoine V., Martin C., Clot J.P., Galen F.X. Protective effect of nitric oxide on isolated rat hepatocytes submitted to an oxidative stress. Metabolism. 51:2002;175-179.
8. Galen F.X., Cottart C.H., Souil E., Dinh-Xuan A.T., Vaubourdolle M., Nivet V., Clot J.P. Role of nitric oxide synthase III and guanosine 3': 5'-cyclic monophosphate in the protection exerted by nitric oxide on hepatic ischemia-reperfusion injury. C. R. Acad. Sci. III. 322:1999;871-877.
9. Bilzer M., Jaeschke H., Vollmar A.M., Paumgartner G., Gerbes A.L. Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am. J. Physiol. 276:1999;G1137-G1144.
10. Waldman S.A., Rapoport R.M., Murad F. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J. Biol. Chem. 259:1984;14332-14334.
11. 2 to improve protein synthesis and transmembrane potential in the postischemic liver. J. Surg. Res. 37:1984;409-414.
12. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:2001;593-615.
13. Fraser J.R., Alcorn D., Laurent T.C., Robinson A.D., Ryan G.B. Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ. Cell Tissue Res. 242:1985;505-510.
14. Ramamurthi A., Lewis R.S. Measurement and modeling of nitric oxide release rate for nitric oxide donors. Chem. Res. Toxicol. 10:1997;408-413.
15. Ogonowski A.A., Kaesemeyer W.H., Jin L., Ganapathy V., Leibach F.H., Caldwell R.W. Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production. Am. J. Physiol. Cell Physiol. 278:2000;C136-C143.
16. Liu P.T., Ioannides C., Symons A.M., Parke D.V. Role of tissue glutathione in prevention of surgical trauma. Xenobiotica. 23:1993;899-911.
17. Vaandrager A.B., de Jonge H.R. Signalling by cGMP-dependent protein kinases. Mol. Cell. Biochem. 157:1996;23-30.
18. von Ruecker A.A., Wild M., Rao G.S., Bidlingmaier F. Atrial natriuretic peptide protects hepatocytes against damage induced by hypoxia and reactive oxygen. Possible role of intracellular free ionized calcium. J. Clin. Chem. Clin. Biochem. 27:1989;531-537.
19. Laskowski I., Pratschke J., Wilhelm M.J., Gasser M., Tilney N.L. Molecular and cellular events associated with ischemia/reperfusion injury. Ann. Transplant. 5:2000;29-35.
20. Kiemer A.K., Vollmar A.M., Bilzer M., Gerwig T., Gerbes A.L. Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-. κ B and AP-1 J. Hepatol. 33:2000;236-246.
21. McCurry K.R., Campbell D.A., Scales W.E., Warren J.S., Remick D.G. Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia-reperfusion. J. Surg Res. 55:1993;49-54.
22. Lee V.G., Johnson M.L., Baust J., Laubach V.E., Watkins S.C., Billiar T.R. The roles of iNOS in liver ischemia-reperfusion injury. Shock. 16:2001;355-360.
23. Pella R. The protective effect of atrial natriuretic peptide (ANP) on cells damaged by oxygen radicals is mediated through elevated CGMP-levels, reduction of calcium-inflow and probably G-proteins. Biochem. Biophys. Res. Commun. 174:1991;549-555.
24. Bilzer M., Witthaut R., Paumgartner G., Gerbes A.L. Prevention of ischemia/reperfusion injury in the rat liver by atrial natriuretic peptide. Gastroenterology. 106:1994;143-151.
25. Krieter P.A., Trapani A.J. Metabolism of atrial natriuretic peptide. Extraction by organs in the rat. Drug Metab. Dispos. 17:1989;14-19.
26. Belzer F.O., Southard J.H. Principles of solid-organ preservation by cold storage. Transplantation. 45:1988;673-676.
27. Michael S.L., Mayeux P.R., Bucci T.J., Warbritton A.R., Irwin L.K., Pumford N.R., Hinson J.A. Acetaminophen-induced hepatotoxicity in mice lacking inducible nitric oxide synthase activity. Nitric Oxide. 5:2001;432-441.
28. Li J., Billiar T.R. Nitric Oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am. J. Physiol. 276:1999;G1069-G1073.
29. Colasanti M., Suzuki H. The dual personality of NO. Trends Pharmacol. Sci. 21:2000;249-252.
30. Kawachi S., Hines I.N., Laroux F.S., Hoffman J., Bharwani S., Gray L., Leffer D., Grisham M.B. Nitric oxide synthase and postischemic liver injury. Biochem. Biophys. Res. Commun. 276:2000;851-854.
31. Hines I.N., Kawachi S., Harada H., Pavlick K.P., Hoffman J.M., Bharwani S., Wolf R.E., Grisham M.B. Role of nitric oxide in liver ischemia and reperfusion injury. Mol. Cell. Biochem. 234-235:2002;229-237.